The present invention describes vaccines that comprise C. perfringens Typealpha toxoids, antigenic fragments thereof, inactivated antigenic fragments ofC. perfringens Type alpha toxins, or any combination thereof. The presentinvention further describes methods of using with these vaccines to protectanimals against clostridial diseases. The present invention also describesmethods of making these vaccines.